Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (309)
- Scheduling (national classification system) (165)
- Advertising (25)
- Safety monitoring and information (23)
- COVID-19 (11)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Clinical trials (4)
- Compliance and enforcement (4)
- Shortages and supply disruptions (3)
- Legislation (2)
- Breast implant hub (1)
- Cosmetics (1)
- Import and export (1)
- Manufacturing (1)
- Prescription opioids hub (1)
Search
580 result(s) found, displaying 476 to 500
-
Scheduling decisions (final)New Chemical Entity (NCE) delegate's final decision and reasons for decision for brexpiprazole
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closed: 31 May 2017
-
Scheduling decisions (final)Delegate-only final decisions to amend the Poisons Standard not referred to an expert advisory committee.
-
Corporate reportsThe TGA's scientific review on the safety of nanoparticles in sunscreens.
-
Scheduling decisions (final)Q&A about changes to the scheduling of codeine.
-
Meeting statementsAdvisory Committee on Prescription Medicines, meeting statement
-
Meeting statementsAdvisory Committee on Prescription Medicines, meeting statement
-
Corporate reportsThese annual summaries provide details of new prescription medicines registrations and information on new or extended uses for existing medicines.
-
Corporate reportsOTC application placement question and answer tool
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 308 statement, 5 February 2016
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 307 statement
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 306 statement
-
Meeting statementsThe Australian Therapeutic Goods Advisory Council met for the sixth time on 17 February 2015
-
Meeting statementsThe Australian Therapeutic Goods Advisory Council met for the seventh time on 4 August 2015
-
Meeting statementsThe meeting statement for the Therapeutic Goods Committee is now available
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 305 statement
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 304 statement
-
Meeting statementsAdvisory Committee on Biologicals (ACB), Meeting 6 statement
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 302 statement
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 303 statement
-
Corporate reportsWe developed a brochure to encourage health professionals to report adverse events or incidents related to the use of medical devices.
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 301 statement
-
Meeting statementsAdvisory Committee on Biologicals, Meeting 5 statement
-
Meeting statementsThe Australian Therapeutic Goods Advisory Council met for the fifth time on 5 August 2014
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 300 statement